{"id":"W2893335845","doi":"10.1007/s40261-018-0705-6","title":"Cost-utility of Sunitinib Versus Pazopanib in Metastatic Renal Cell Carcinoma in Canada using Real-world Evidence","year":2018,"lang":"en","type":"article","venue":"Clinical Drug Investigation","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"ca_institutions":"Centre hospitalier universitaire de Québec; University of Alberta; McGill University Health Centre; University of Ottawa; Centre Hospitalier de l’Université de Montréal; Princess Margaret Cancer Centre; University of Calgary; Sunnybrook Hospital; Queen Elizabeth II Health Sciences Centre; University of British Columbia; University of Toronto; Dalhousie University; McMaster University","funders":"Fonds de Recherche du Québec - Santé; Canadian Centre for Applied Research in Cancer Control","keywords":"Pazopanib; Sunitinib; Medicine; Renal cell carcinoma; Internal medicine; Oncology; Cost effectiveness; Intensive care medicine","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003677483,0.0007706225,0.001419419,0.001939633,0.0008032359,0.003187496,0.001514942,0.0009419722,0.003400619],"category_scores_gemma":[0.02700711,0.0003722878,0.003191087,0.004821119,0.001046585,0.001287827,0.0009348847,0.001742347,0.0001364607],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.07067843,"about_ca_system_score_gemma":0.05586422,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9535376,"about_ca_topic_score_gemma":0.9670415,"domain_scores_codex":[0.9968255,0.001134491,0.0003110681,0.0003032653,0.0008458087,0.0005798645],"domain_scores_gemma":[0.9891221,0.004643944,0.001934833,0.0002371368,0.00285387,0.001208212],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0269089,0.0007613357,0.6824092,0.007927469,0.01894603,0.0009341646,0.0003705549,0.1348335,0.0004265451,0.008271999,0.02348402,0.09472638],"study_design_scores_gemma":[0.008381275,0.002838932,0.7538456,0.005443563,0.03275015,0.0009389666,0.002423317,0.1554139,0.0009196737,0.006760685,0.02988715,0.0003968047],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8581622,0.06842841,0.001548103,0.0139979,0.0002958488,0.000733569,0.04049351,0.00008638078,0.01625418],"genre_scores_gemma":[0.9871257,0.006765544,0.0007527624,0.0004568603,0.00004805675,0.00004665964,0.004276641,0.00001168991,0.0005161529],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07067843,"threshold_uncertainty_score":0.5128103,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3289610242284381,"score_gpt":0.4109753416940739,"score_spread":0.08201431746563581,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}